Searchable abstracts of presentations at key conferences in endocrinology

ea0029p304 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Cardiovascular risk factors in a large cohort of children with GH deficiency

De Martino L. , Capalbo D. , Esposito A. , Cerbone M. , Improda N. , Rezzuto M. , Salerno M.

Background: Adults with GH deficiency (GHD) may have an increased risk of cardiovascular disease. Several studies showed that also GHD children may present cardiovascular risk factors. However results are controversial.Objective: Aim of this prospective, case-control study on a large cohort of children with GHD was to evaluate the effects of GHD and GH therapy on cardiovascular risk factors, such as lipid profile, clinical measures of visceral adiposity ...

ea0011p939 | Thyroid | ECE2006

Antiproliferative effects of SOM230 on orbital fibroblasts from active Graves’ ophthalmophaty

Pasquali D , Rossi V , Bellastella G , Esposito D , Quinto MC , Bellastella A , Sinisi AA

Recently it has been shown that somatostatin (SST) might be of therapeutic value in the treatment of active GravesÂ’ophthalmopathy (GO). SST and somatostatin receptors (sst) transcripts are expressed and functional in cultured orbital fibroblasts deriving from GO patients (FGO). Octreotide, the SST analogue currently used is able to inhibit in vitro growth and activity of FGO. New analogues with wider sst-affinity are now available for in vitro experim...

ea0029p1124 | Neuroendocrinology | ICEECE2012

Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment

Accardo G. , Renzullo A. , De Bellis A. , Bizzarro A. , Romano M. , Federico A. , Gravina A. , Faggiano A. , Marotta V. , Esposito D. , Bellastella A. , Pasquali D.

Autoimmune chronic thyroid disease (AITD) is associated with atrophic gastritis (CAG) in 29–42% of the cases. CAG and the consequent hypergastrinemia, listed as precancerous lesion, can predispose to neuroendocrine cells hyperplasia and the development of neuroendocrine gastric tumors (NET). Aim of this study was to evaluate the association of AITD with risk of gastric NET and the efficacy of somatostatin analogues treatment.Patients: From 2009 to 2...